Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature

J. F. Camargo, G. J. Tobón, N. Fonseca, J. L. Diaz, M. Uribe, F. Molina, Juan Manuel Anaya

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Autoimmune rheumatic diseases (AIRD) are not uncommon in the general population and up to one third of hospitalized patients with AIRD may need admission to intensive care unit (ICU). This paper describes the causes of admission, the clinical features and outcome of 24 AIRD patients admitted to a medical ICU from a third level hospital. Thirteen patients had systemic lupus erythematosus (54.2%), three rheumatoid arthritis (12.5%), three pulmonary renal syndrome (12.5%), two dermatopolymyositis (8.3%), two scleroderma (8.3%) and one antiphospholipid syndrome (4.2%). The main causes for ICU admission were rheumatic disease flare-up (37.5%), infection (37.5%) and complications derived from rheumatic disease (29.1%). Mortality during ICU stay was 16.7% (four patients). Excluding shock requiring vasopressor support, no statistical difference was found between survivors and nonsurvivors; although there was a trend to higher test severity scores (APACHE II, ODIN) in nonsurvivors. Our results reveal a lower mortality rate in AIRD patients admitted to the ICU than reported previously. Severity scores such as APACHE II are predictors of mortality in patients with AIRD in the ICU. © 2005 Edward Arnold (Publishers) Ltd.
Original languageEnglish (US)
Pages (from-to)315-320
Number of pages6
JournalLupus
DOIs
StatePublished - May 4 2005

Fingerprint

Rheumatic Diseases
Tertiary Care Centers
Autoimmune Diseases
Intensive Care Units
APACHE
Mortality
Dermatomyositis
Antiphospholipid Syndrome
Systemic Lupus Erythematosus
Survivors
Shock
Rheumatoid Arthritis
Infection
Population

Cite this

Camargo, J. F. ; Tobón, G. J. ; Fonseca, N. ; Diaz, J. L. ; Uribe, M. ; Molina, F. ; Anaya, Juan Manuel. / Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature. In: Lupus. 2005 ; pp. 315-320.
@article{1d01cabdc48c4d8491dd8789500109b3,
title = "Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature",
abstract = "Autoimmune rheumatic diseases (AIRD) are not uncommon in the general population and up to one third of hospitalized patients with AIRD may need admission to intensive care unit (ICU). This paper describes the causes of admission, the clinical features and outcome of 24 AIRD patients admitted to a medical ICU from a third level hospital. Thirteen patients had systemic lupus erythematosus (54.2{\%}), three rheumatoid arthritis (12.5{\%}), three pulmonary renal syndrome (12.5{\%}), two dermatopolymyositis (8.3{\%}), two scleroderma (8.3{\%}) and one antiphospholipid syndrome (4.2{\%}). The main causes for ICU admission were rheumatic disease flare-up (37.5{\%}), infection (37.5{\%}) and complications derived from rheumatic disease (29.1{\%}). Mortality during ICU stay was 16.7{\%} (four patients). Excluding shock requiring vasopressor support, no statistical difference was found between survivors and nonsurvivors; although there was a trend to higher test severity scores (APACHE II, ODIN) in nonsurvivors. Our results reveal a lower mortality rate in AIRD patients admitted to the ICU than reported previously. Severity scores such as APACHE II are predictors of mortality in patients with AIRD in the ICU. {\circledC} 2005 Edward Arnold (Publishers) Ltd.",
author = "Camargo, {J. F.} and Tob{\'o}n, {G. J.} and N. Fonseca and Diaz, {J. L.} and M. Uribe and F. Molina and Anaya, {Juan Manuel}",
year = "2005",
month = "5",
day = "4",
doi = "10.1191/0961203305lu2082oa",
language = "English (US)",
pages = "315--320",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",

}

Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature. / Camargo, J. F.; Tobón, G. J.; Fonseca, N.; Diaz, J. L.; Uribe, M.; Molina, F.; Anaya, Juan Manuel.

In: Lupus, 04.05.2005, p. 315-320.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature

AU - Camargo, J. F.

AU - Tobón, G. J.

AU - Fonseca, N.

AU - Diaz, J. L.

AU - Uribe, M.

AU - Molina, F.

AU - Anaya, Juan Manuel

PY - 2005/5/4

Y1 - 2005/5/4

N2 - Autoimmune rheumatic diseases (AIRD) are not uncommon in the general population and up to one third of hospitalized patients with AIRD may need admission to intensive care unit (ICU). This paper describes the causes of admission, the clinical features and outcome of 24 AIRD patients admitted to a medical ICU from a third level hospital. Thirteen patients had systemic lupus erythematosus (54.2%), three rheumatoid arthritis (12.5%), three pulmonary renal syndrome (12.5%), two dermatopolymyositis (8.3%), two scleroderma (8.3%) and one antiphospholipid syndrome (4.2%). The main causes for ICU admission were rheumatic disease flare-up (37.5%), infection (37.5%) and complications derived from rheumatic disease (29.1%). Mortality during ICU stay was 16.7% (four patients). Excluding shock requiring vasopressor support, no statistical difference was found between survivors and nonsurvivors; although there was a trend to higher test severity scores (APACHE II, ODIN) in nonsurvivors. Our results reveal a lower mortality rate in AIRD patients admitted to the ICU than reported previously. Severity scores such as APACHE II are predictors of mortality in patients with AIRD in the ICU. © 2005 Edward Arnold (Publishers) Ltd.

AB - Autoimmune rheumatic diseases (AIRD) are not uncommon in the general population and up to one third of hospitalized patients with AIRD may need admission to intensive care unit (ICU). This paper describes the causes of admission, the clinical features and outcome of 24 AIRD patients admitted to a medical ICU from a third level hospital. Thirteen patients had systemic lupus erythematosus (54.2%), three rheumatoid arthritis (12.5%), three pulmonary renal syndrome (12.5%), two dermatopolymyositis (8.3%), two scleroderma (8.3%) and one antiphospholipid syndrome (4.2%). The main causes for ICU admission were rheumatic disease flare-up (37.5%), infection (37.5%) and complications derived from rheumatic disease (29.1%). Mortality during ICU stay was 16.7% (four patients). Excluding shock requiring vasopressor support, no statistical difference was found between survivors and nonsurvivors; although there was a trend to higher test severity scores (APACHE II, ODIN) in nonsurvivors. Our results reveal a lower mortality rate in AIRD patients admitted to the ICU than reported previously. Severity scores such as APACHE II are predictors of mortality in patients with AIRD in the ICU. © 2005 Edward Arnold (Publishers) Ltd.

U2 - 10.1191/0961203305lu2082oa

DO - 10.1191/0961203305lu2082oa

M3 - Article

SP - 315

EP - 320

JO - Lupus

JF - Lupus

SN - 0961-2033

ER -